De Addiction Drugs

Pioneers in the industry, we offer naltrexone 50mg tablets, naltrexone 50mg tablet, varenicline tartrate tablet and low dose naltrexone (ldn) hcl 3 mg tablets from India.

Naltrexone 50mg Tablets

Request Callback

₹ 300 / Stripe Get Latest Price

Product Brochure
Strength50 mg
Packaging Size1x10
Packaging TypeBox
Dose50 mg
Usage/ApplicationClinical
BrandNaltima 50 mg
Also GivesThird Party Manufacturing
Product TypeFinished Product
FormTablet
GradeA
Manufactured ByINTAS
TypeTablet
CompositionNaltrexone 50
Country of OriginMade in India
Naltrexone 50 Tablet is used in the treatment of opioid dependence and alcohol addiction. It works by blocking the euphoric feelings (highs) that Some people may experience after taking opiates and alcohol. This reduces the craving and helps you stay away from them.

Naltrexone 50mg Tablet

Request Callback

₹ 800 / Stripe Get Latest Price

Product Brochure
Packaging Typebox of 10*3 Stripe
Usage/ApplicationClinical
BrandNodict 50
Also GivesThird Party Manufacturing
Product TypeFinished Product
FormTablet
Is It ISO CertifiedISO Certified
Manufactured BySun Pharma
Nodict 50mg Tablet is used in the treatment of opioid dependence and alcohol addiction. It works by blocking the euphoric feelings (highs) that Some people may experience after taking opiates and alcohol. This reduces the craving and helps you stay away from them.

Varenicline Tartrate Tablet

Request Callback

₹ 1500 / Box Get Latest Price

Product Brochure
Strength1 mg
Packaging TypeBox
BrandVARENISMART
FormTablets
ManufacturerHealing Pharma
Country of OriginMade in India
Varenicline is used along with education and counseling to help people stop smoking. Varenicline is in a class of medications called smoking cessation aids. It works by blocking the pleasant effects of nicotine (from smoking) on the brain.

Low Dose Naltrexone (LDN) HCL 3 mg Tablets

Request Callback

₹ 700 / Stripe Get Latest Price

Product Brochure
Packaging Size30 capsules
Packaging TypeBox
Dose3 mg
BrandLow Dose Naltrexone
Also GivesThird Party Manufacturing
Product TypeFinished Product
Low-dose naltrexone (LDN) has been demonstrated to reduce symptom severity in conditions such as fibromyalgia, Crohn’s disease, multiple sclerosis, and complex regional pain syndrome. We review the evidence that LDN may operate as a novel anti-inflammatory agent in the central nervous system, via action on microglial cells. These effects may be unique to low dosages of naltrexone and appear to be entirely independent from naltrexone’s better-known activity on opioid receptors. As a daily oral therapy, LDN is inexpensive and well-tolerated. Despite initial promise of efficacy, the use of LDN for chronic disorders is still highly experimental. Published trials have low sample sizes, and few replications have been performed. We cover the typical usage of LDN in clinical trials, caveats to using the medication, and recommendations for future research and clinical work. LDN may represent one of the first glial cell modulators to be used for the management of chronic pain disorders.
X

Contact Us

Vikas Jagdish Bhatia (CEO)
Vekas Medicare
First Floor, Plot No 230,Flat, No 4 Gurunanak, Co. OP Housing Society Nara, Road
Jaripatka, Nagpur - 440014, Maharashtra, India

Get Directions
Send Email
Share: